| Literature DB >> 29735399 |
Madhu Chaturvedi1, Justin Schilling2, Alexandre Beautrait3, Michel Bouvier4, Jeffrey L Benovic2, Arun K Shukla5.
Abstract
G protein-coupled receptors (GPCRs) recognize a diverse array of extracellular stimuli, and they mediate a broad repertoire of signaling events involved in human physiology. Although the major effort on targeting GPCRs has typically been focused on their extracellular surface, a series of recent developments now unfold the possibility of targeting them from the intracellular side as well. Allosteric modulators binding to the cytoplasmic surface of GPCRs have now been described, and their structural mechanisms are elucidated by high-resolution crystal structures. Furthermore, pepducins, aptamers, and intrabodies targeting the intracellular face of GPCRs have also been successfully utilized to modulate receptor signaling. Moreover, small molecule compounds, aptamers, and synthetic intrabodies targeting β-arrestins have also been discovered to modulate GPCR endocytosis and signaling. Here, we discuss the emerging paradigm of intracellular targeting of GPCRs, and outline the current challenges, potential opportunities, and future outlook in this particular area of GPCR biology.Entities:
Keywords: G protein-coupled receptors; allosteric modulators; barbadin; intrabodies; pepducins; β-arrestins
Mesh:
Substances:
Year: 2018 PMID: 29735399 PMCID: PMC7258685 DOI: 10.1016/j.tibs.2018.04.003
Source DB: PubMed Journal: Trends Biochem Sci ISSN: 0968-0004 Impact factor: 13.807